SCHEMBL1160811

SCHEMBL1160811

Oc1ccc(-c2cnc3ccccc3n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 1.00
NPC1 O15118 8/20 0.68
RAB9A P51151 7/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
AR P10275 1/20 0.59
MAPT P10636 7/20 0.58
KDM4E B2RXH2 3/20 0.58
KMT2A Q03164 6/20 0.57
MEN1 O00255 4/20 0.57
ALDH1A1 P00352 3/20 0.57
ALOX12 P18054 1/20 0.57
MAPK10 P53779 1/20 0.57
ATM Q13315 1/20 0.57
MAPK1 P28482 1/20 0.56
RIPK1 Q13546 1/20 0.56
HPGD P15428 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954320 0.90 NPC1 (0.81) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL24596471 0.84 NPC1 (0.72) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL708285 0.84 NPC1 (0.72) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL87505 0.84 NPC1 (0.71) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL29371290 0.84 NPC1 (0.71) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28852479 0.83 BCHE (0.71) BCHENPC1RAB9ASMN1; SMN2MAPT
Water SCHEMBL27478798 0.82 NPC1 (0.69) BCHENPC1RAB9ASMN1; SMN2MAPT
Water SCHEMBL5134592 0.82 NPC1 (0.69) BCHENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28165461 0.81 BCHE (0.68) BCHENPC1RAB9ASMN1; SMN2AR
SCHEMBL708043 0.81 NPC1 (1.00) BCHENPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105061762-B Side chain-bisphenol type quinoxalinyl benzoxazine resin 哈尔滨工程大学 2017-04-12 CN disclosed
CN-105061762-A Side chain-bisphenol type quinoxalinyl benzoxazine resin UNIV HARBIN ENG 2015-11-18 CN disclosed
US-8569295-B2 Bicyclic urea compounds MERCK PATENT GMBH (DE) 2013-10-29 US disclosed
EP-2461869-B1 NOVEL BICYCLIC UREA COMPOUNDS MERCK PATENT GMBH (DE) 2013-08-21 EP disclosed
US-20120190654-A1 NOVEL BICYCLIC UREA COMPOUNDS MERCK PATENT GMBH (DE) 2012-07-26 US disclosed
EP-2461869-A1 NOVEL BICYCLIC UREA COMPOUNDS Merck Patent GmbH (DE) 2012-06-13 EP disclosed
WO-2011017142-A1 NOVEL BICYCLIC UREA COMPOUNDS MERCK PATENT GMBH (DE) 2011-02-10 WO disclosed
CN-1006386-B PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER SHINETSU CHEM IND CO (JP) 1990-01-10 CN disclosed
CN-85107531-A Process for producing vinyl chloride polymer 1987-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190654-A1 NOVEL BICYCLIC UREA COMPOUNDS CCNC, CCNI, CCNA1 BCHE 2031/4885NPC1 1489/4885RAB9A 1974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.